Literature DB >> 35443700

Correction to: Are pro-infammatory markers associated with psychological distress in a cross-sectional study of healthy adolescents 15-17 years of age? The Fit Futures study.

Jonas Linkas1, Luai Awad Ahmed2, Gabor Csifcsak3, Nina Emaus4, Anne-Sofe Furberg5, Guri Grimnes6,7, Gunn Pettersen4, Kamilla Rognmo3, Tore Christofersen4,8,9.   

Abstract

Entities:  

Year:  2022        PMID: 35443700      PMCID: PMC9022307          DOI: 10.1186/s40359-022-00812-w

Source DB:  PubMed          Journal:  BMC Psychol        ISSN: 2050-7283


× No keyword cloud information.

Correction to: BMC Psychology (2022) 10:65 10.1186/s40359-022-00779-8

Following publication of the original article [1], the authors flagged that the article had published with errors in Tables 1 and 2: IL6-α TGF-α TRANCE TWEAK had been given the unit pg/L rather than the (correct) unit NPX.
Table 1

Characteristics by psychological distress for girls. Fit Futures 2010–2011 (n = 458)

With psychological distressWithout psychological distressp-value*
nMean (SD)nMean (SD)
Age in years mean (SD)12316.15 (0.44)33516.13 (0.41)0.23
Body fat percentage, dichotomous1233320.03
 < 3033.3%44.9%
 ≥ 3066.7%55.1%
Age menarche (years)1213310.88
 Early (≤ 12.68)39.7%40.5%
 Late (> 12.68)60.3%59.5%
Smoking123334< 0.01
 No, never62.6%85.9%
 Yes37.4%14.1%
Snuffing123334< 0.01
 No, never53.7%71.3%
 Yes46.3%28.7%
Alcohol1233350.01
 Never14.6%26.6%
 Once per month or less46.3%46.6%
 Twice or more per month39.0%26.9%
Physical activity123335< 0.01
 Sedentary22.0%11.3%
 Active78.0%88.7%
Sleep (hours)123334< 0.01
 Low (≤ 7)51.2%34.7%
 High (> 7)48.8%65.3%
Current infection1223340.20
 No82.8%87.4%
 Yes17.2%12.6%
Chronic disease1223340.01
 No59.9%72.2%
 Yes41.0%27.8%
Hormonal contraceptives122333< 0.01
 No50.8%65.8%
 Yes49.2%34.2%
Intake of medication1223340.05
 No59.8%69.8%
 Yes40.2%30.2%
High School Program1233350.02
 General studies45.5%54.3%
 Sports and physical4.9%9.6%
 Vocational49.6%36.1%
 CRP mg/L median and IQR970.72 (1.39)2970.47 (1.08)0.11
IL-6 NPX median and IQR982.79 (0.59)3002.68 (0.57)0.05
TGF- α NPX median and IQR983.90 (0.80)3003.90 (0.71)0.91
TRANCE NPX median and IQR985.62 (0.77)3005.53 (0.76)1.00
TWEAK NPX median and IQR988.94 (0.51)3008.88 (0.42)0.87
Vitamin D nmol/L median and IQR9839.36 (25.94)30041.90 (24.07)0.65

*Chi-square for categorical variables and t-test or Mann Whitney U for continuous variables

With psychological distress: a score above 1.85 on HSCL-10

Without psychological distress: a score below 1.85 on HSCL-10

Mean (SD) of continuous variable and percentages of categorical variables are reported

Median and IQR are reported for inflammatory markers and Vitamin D

Intake of medication: Intake of medications, analgetics or antibiotics in the last 24 h

CRP C-reactive protein, IL6-α Interleukin 6 alpha, TGF-α Transforming growth factor alpha, TRANCE Tumor Necrosis Factor-related activation-induced cytokine (O14788: TNF-related activation-induced cytokine within limits of detection), TWEAK Tumor necrosis factor-like weak inducer of apoptosis (O43508: TNF-like weak inducer of apoptosis within limits of detection), NPX Normalized protein expression, Vitamin D Standardized version of (25-OH)D

Table 2

Characteristics by psychological distress for boys. Fit Futures 2010–2011, (n = 473)

With psychological distressWithout psychological distressp-value*
nMean (SD)nMean (SD)
Age in years mean (SD)5116.14 (0.49)42216.05 (0.45)0.09
Body fat percentage, dichotomous504220.41
 < 2568%73.5%
 ≥ 2532%26.5%
PDS status423340.52
 Completed23.8%16.8%
 Underway69.0%74.6%
 Barely started7.1%8.7%
 Not begun0%0%
Smoking514220.07
 No, never66.7%78.0%
 Yes33.3%22.0%
Snuffing514210.50
 No, never54.9%59.9%
 Yes45.1%40.1%
Alcohol514200.32
 Never31.4%32.9%
 Once per month or less29.4%37.6%
 Twice or more per month39.2%29.5%
Physical activity51422< 0.01
 Sedentary49.0%27.0%
 Active51.0%73.0%
Sleep (h)514150.01
 Low (≤ 7)74.5%54.9%
 High (> 7)25.5%45.1%
Current infection514210.86
 No86.3%87.2%
 Yes13.7%12.8%
Chronic disease514200.02
 No58.8%74.8%
 Yes41.2%25.2%
Intake of medication514210.57
 No78.4%81.7%
 Yes21.6%18.3%
High school program514220.12
 General studies39.2%28.7%
 Sports and physical5.9%14.7%
 Vocational54.9%56.6%
CRP mg/L median and IQR440.47 (1.22)3850.49 (0.78)0.64
IL-6 NPX median and IQR472.76 (0.61)3982.72 (0.62)0.82
TGF-α NPX median and IQR473.75 (0.68)3983.61 (0.74)0.09
TRANCE NPX median and IQR476.01 (0.77)3986.04 (0.65)0.99
TWEAK NPX median and IQR479.00 (0.30)3989.02 (0.37)0.15
Vitamin D nmol/L Median and IQR4725.91 (15.81)39930.44 (21.43)0.01

*Chi-square for categorical variables and t-test or Mann Whitney U for continuous variables

With psychological distress: a score above 1.85 on HSCL-10

Without psychological distress: a score below 1.85 on HSCL-10

Mean (SD) of continuous variable and percentages of categorical variables are reported

Median and IQR are reported for inflammatory markers and Vitamin D

PDS status Pubertal Development Scale status, Intake of medication intake of medications, analgetics or antibiotics in the last 24 h, CRP C-reactive protein, IL6-α Interleukin 6 alpha, TGF-α Transforming growth factor alpha, TRANCE Tumor Necrosis Factor-related activation-induced cytokine (O14788: TNF-related activation-induced cytokine within limits of detection), TWEAK Tumor necrosis factor-like weak inducer of apoptosis (O43508: TNF-like weak inducer of apoptosis within limits of detection), NPX Normalized protein expression, Vitamin D Standardized version of (25-OH)D

The tables have now been corrected in the published article, and the corrected tables may be seen in this erratum for reference. The authors thank you for reading this correction and apologize for any inconvenience caused. Characteristics by psychological distress for girls. Fit Futures 2010–2011 (n = 458) *Chi-square for categorical variables and t-test or Mann Whitney U for continuous variables With psychological distress: a score above 1.85 on HSCL-10 Without psychological distress: a score below 1.85 on HSCL-10 Mean (SD) of continuous variable and percentages of categorical variables are reported Median and IQR are reported for inflammatory markers and Vitamin D Intake of medication: Intake of medications, analgetics or antibiotics in the last 24 h CRP C-reactive protein, IL6-α Interleukin 6 alpha, TGF-α Transforming growth factor alpha, TRANCE Tumor Necrosis Factor-related activation-induced cytokine (O14788: TNF-related activation-induced cytokine within limits of detection), TWEAK Tumor necrosis factor-like weak inducer of apoptosis (O43508: TNF-like weak inducer of apoptosis within limits of detection), NPX Normalized protein expression, Vitamin D Standardized version of (25-OH)D Characteristics by psychological distress for boys. Fit Futures 2010–2011, (n = 473) *Chi-square for categorical variables and t-test or Mann Whitney U for continuous variables With psychological distress: a score above 1.85 on HSCL-10 Without psychological distress: a score below 1.85 on HSCL-10 Mean (SD) of continuous variable and percentages of categorical variables are reported Median and IQR are reported for inflammatory markers and Vitamin D PDS status Pubertal Development Scale status, Intake of medication intake of medications, analgetics or antibiotics in the last 24 h, CRP C-reactive protein, IL6-α Interleukin 6 alpha, TGF-α Transforming growth factor alpha, TRANCE Tumor Necrosis Factor-related activation-induced cytokine (O14788: TNF-related activation-induced cytokine within limits of detection), TWEAK Tumor necrosis factor-like weak inducer of apoptosis (O43508: TNF-like weak inducer of apoptosis within limits of detection), NPX Normalized protein expression, Vitamin D Standardized version of (25-OH)D
  1 in total

1.  Are pro-inflammatory markers associated with psychological distress in a cross-sectional study of healthy adolescents 15-17 years of age? The Fit Futures study.

Authors:  Jonas Linkas; Luai Awad Ahmed; Gabor Csifcsak; Nina Emaus; Anne-Sofie Furberg; Guri Grimnes; Gunn Pettersen; Kamilla Rognmo; Tore Christoffersen
Journal:  BMC Psychol       Date:  2022-03-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.